Abstract
Osteoarthritis (OA) is a complex disease plagued by a significant unmet need for treatment. To date, no disease- modifying OA drugs (DMOADs) exist and the available symptom-modifying OA drugs (SMOADs) have limitations. Although a complete understanding of the mechanisms of OA pain in humans is lacking, animal models have helped provide insight into the multifaceted origin and manifestation of OA pain. Success in discovering new therapeutics will likely require reliance on good animal models. This review summarizes the animal models available for studying pain associated with OA.
Keywords: Osteoarthritis, pain, nociception, animal models, DMOAD, SMOAD, disease-modifying OA drugs (DMOADs), symptom-modifying OA drugs (SMOADs), manifestation of OA pain, bone marrow lesions, synovial proliferation, magnetic resonance imaging, high resolution computer tomography (HRCT), bone marrow edema, Joint pain
Current Pharmaceutical Biotechnology
Title: A Review of Current Animal Models of Osteoarthritis Pain
Volume: 12 Issue: 10
Author(s): Warren N. D'Souza, Gordon Y. Ng, Bradley D. Youngblood, Wayne Tsuji and Sonya G. Lehto
Affiliation:
Keywords: Osteoarthritis, pain, nociception, animal models, DMOAD, SMOAD, disease-modifying OA drugs (DMOADs), symptom-modifying OA drugs (SMOADs), manifestation of OA pain, bone marrow lesions, synovial proliferation, magnetic resonance imaging, high resolution computer tomography (HRCT), bone marrow edema, Joint pain
Abstract: Osteoarthritis (OA) is a complex disease plagued by a significant unmet need for treatment. To date, no disease- modifying OA drugs (DMOADs) exist and the available symptom-modifying OA drugs (SMOADs) have limitations. Although a complete understanding of the mechanisms of OA pain in humans is lacking, animal models have helped provide insight into the multifaceted origin and manifestation of OA pain. Success in discovering new therapeutics will likely require reliance on good animal models. This review summarizes the animal models available for studying pain associated with OA.
Export Options
About this article
Cite this article as:
N. D'Souza Warren, Y. Ng Gordon, D. Youngblood Bradley, Tsuji Wayne and G. Lehto Sonya, A Review of Current Animal Models of Osteoarthritis Pain, Current Pharmaceutical Biotechnology 2011; 12 (10) . https://dx.doi.org/10.2174/138920111798357320
DOI https://dx.doi.org/10.2174/138920111798357320 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecularly Guided Therapy of Neuroblastoma: A Review of Different Approaches
Current Pharmaceutical Design An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Medicinal Chemistry Reviews - Online (Discontinued) Aluminofluoride Complexes: Phosphate Analogues and a Hidden Hazard for Living Organisms
Current Inorganic Chemistry (Discontinued) Nanoparticles based on oleate alginate ester as curcumin delivery system
Current Drug Delivery An Efficient Cancer Classification Model for CT/MRI/PET Fused Images
Current Medical Imaging A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines
Current Pharmaceutical Design Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects
Current Pharmaceutical Design WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Anti-Cancer Agents in Medicinal Chemistry Biomarkers and Osteosarcoma and IGF
Recent Patents on Biomarkers Molecular Mechanisms of Thymoquinone as Anticancer Agent
Combinatorial Chemistry & High Throughput Screening Targeting the Multidrug ABCG2 Transporter with Flavonoidic Inhibitors: In Vitro Optimization and In Vivo Validation
Current Medicinal Chemistry Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Current Signal Transduction Therapy GRP78 Influences Chemoresistance and Prognosis in Cancer
Current Drug Targets PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA Pharmacogenetics of Drug Transporters and Its Impact on the Pharmacotherapy
Current Topics in Medicinal Chemistry The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target
Current Medicinal Chemistry Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine
Current Drug Metabolism Biological Evidence for the Benefit of Green Tea and EGCG in Arthritis
Current Rheumatology Reviews Cyclodextrin-Based Delivery Systems for Arthritic Diseases: From Development to Experimental Therapeutics
Current Pharmaceutical Design